ATE131074T1 - Festes matrixsystem zur transdermalen arzneimittelfreisetzung. - Google Patents

Festes matrixsystem zur transdermalen arzneimittelfreisetzung.

Info

Publication number
ATE131074T1
ATE131074T1 AT90309608T AT90309608T ATE131074T1 AT E131074 T1 ATE131074 T1 AT E131074T1 AT 90309608 T AT90309608 T AT 90309608T AT 90309608 T AT90309608 T AT 90309608T AT E131074 T1 ATE131074 T1 AT E131074T1
Authority
AT
Austria
Prior art keywords
drug release
release matrix
transdermal drug
matrix system
matrix
Prior art date
Application number
AT90309608T
Other languages
English (en)
Inventor
Chia-Ming Chiang
Renee Ann Tenzel
Original Assignee
Cygnus Therapeutic Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23604513&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE131074(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cygnus Therapeutic Systems filed Critical Cygnus Therapeutic Systems
Application granted granted Critical
Publication of ATE131074T1 publication Critical patent/ATE131074T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
AT90309608T 1989-09-08 1990-09-03 Festes matrixsystem zur transdermalen arzneimittelfreisetzung. ATE131074T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40563089A 1989-09-08 1989-09-08

Publications (1)

Publication Number Publication Date
ATE131074T1 true ATE131074T1 (de) 1995-12-15

Family

ID=23604513

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90309608T ATE131074T1 (de) 1989-09-08 1990-09-03 Festes matrixsystem zur transdermalen arzneimittelfreisetzung.

Country Status (15)

Country Link
EP (1) EP0416842B1 (de)
JP (3) JP2718433B2 (de)
AT (1) ATE131074T1 (de)
AU (1) AU644815B2 (de)
CA (1) CA2065311C (de)
DE (1) DE69023992T2 (de)
DK (1) DK0416842T3 (de)
ES (1) ES2081352T3 (de)
FI (1) FI107708B (de)
GR (1) GR3019124T3 (de)
IE (1) IE71048B1 (de)
NO (1) NO303262B1 (de)
NZ (1) NZ235068A (de)
PT (1) PT95245B (de)
WO (1) WO1991003219A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5560922A (en) * 1986-05-30 1996-10-01 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit using a polyacrylate adhesive polymer and process
US6110488A (en) * 1986-08-28 2000-08-29 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system, its use and production process
US6117448A (en) * 1986-08-28 2000-09-12 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system, its use and production process
US6139868A (en) * 1986-08-28 2000-10-31 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system, its use and production process
US6126963A (en) 1986-08-28 2000-10-03 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system, its use and production process
USRE37934E1 (en) 1986-08-28 2002-12-10 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system
US5820876A (en) * 1986-08-28 1998-10-13 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5246706A (en) * 1991-07-19 1993-09-21 Cygnus Therapeutic Systems Device for administering bimakalim transdermally
DE4229820C2 (de) * 1992-09-07 1998-12-03 Jenapharm Gmbh Pharmazeutische Zubereitung auf Gestagen-Basis
US5919478A (en) * 1993-06-25 1999-07-06 Alza Corporation Incorporating poly-N-vinyl amide in a transdermal system
US5460820B1 (en) † 1993-08-03 1999-08-03 Theratech Inc Method for providing testosterone and optionally estrogen replacement therapy to women
US5554381A (en) * 1993-08-09 1996-09-10 Cygnus, Inc. Low flux matrix system for delivering potent drugs transdermally
DE4333595A1 (de) * 1993-10-01 1995-04-06 Labtec Gmbh Transdermales therapeutisches System zur Applikation von Arzneimitteln auf die Haut
GR1002079B (en) * 1994-07-26 1995-12-05 Lavipharm A E System of a special structure and composition for the rapid transdermal administration of oestrogens.
WO1996008255A1 (en) * 1994-09-14 1996-03-21 Minnesota Mining And Manufacturing Company Transdermal device for delivery of levonorgestrel
US5780050A (en) * 1995-07-20 1998-07-14 Theratech, Inc. Drug delivery compositions for improved stability of steroids
DE19526864A1 (de) * 1995-07-22 1997-01-23 Labtec Gmbh Hormonpflaster
DE19548332A1 (de) * 1995-12-22 1997-07-10 Rotta Res Bv Hormonpflaster
DE19631084A1 (de) 1996-08-01 1998-02-05 Basf Ag Verwendung von (Meth)acrylsäure-Copolymeren zur Erhöhung der Permeabilität der Schleimhaut
DE19701949A1 (de) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
JP4477152B2 (ja) * 1997-05-16 2010-06-09 株式会社共和 ストーマ用又は瘡傷用の皮膚保護材
DE19827732A1 (de) * 1998-06-22 1999-12-23 Rottapharm Bv Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie
DE19834007C1 (de) * 1998-07-29 2000-02-24 Lohmann Therapie Syst Lts Estradiolhaltiges Pflaster zur transdermalen Applikation von Hormonen und seine Verwendung
JP3528739B2 (ja) 2000-02-16 2004-05-24 日産自動車株式会社 エンジンの排気浄化装置
US20020119187A1 (en) * 2000-09-29 2002-08-29 Cantor Adam S. Composition for the transdermal delivery of fentanyl
JP3935839B2 (ja) * 2000-11-17 2007-06-27 帝三製薬株式会社 エストラジオール含有貼付剤
ES2270746T3 (es) * 2001-03-16 2007-12-01 Alza Corporation Parche transdermico para administrar fentanilo.
DE10141652B4 (de) * 2001-08-24 2011-04-07 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung
DE10141650C1 (de) * 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
JP4194277B2 (ja) 2002-01-25 2008-12-10 久光製薬株式会社 架橋ポリマーを主成分とする粘着性成形体の製造方法
WO2006064747A1 (ja) 2004-12-15 2006-06-22 Saitama Daiichi Pharmaceutical Co., Ltd. 医療用テープ剤
DE102004062182B4 (de) * 2004-12-20 2007-06-06 Bayer Schering Pharma Ag Transdermales Pflaster mit Progesteron A-Spezifische Liganden (PRASL) als Wirkstoff
EP2255809B1 (de) 2008-02-27 2017-08-23 Hisamitsu Pharmaceutical Co., Inc. Mit arzneistoff versetztes pflaster
FR2992325B1 (fr) 2012-06-26 2015-05-22 Ab7 Innovation Matrice sequencee multifonctionnelle monopolymerique en polyurethane coule et procede de fabrication
JP6125547B2 (ja) * 2013-04-24 2017-05-10 あすか製薬株式会社 無定形レボノルゲストレル、固体分散体及びそれらの製造方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3632740A (en) * 1968-06-13 1972-01-04 Johnson & Johnson Topical device for the therapeutic management of dermatological lesions with steroids
US3769071A (en) * 1971-06-04 1973-10-30 Minnesota Mining & Mfg Pressure sensitive adhesive tape comprising 5-fluorouracil
US3896789A (en) * 1974-06-10 1975-07-29 Riker Laboratories Inc Retinoic acid dipensing pressure sensitive dermotological tape
JPS5843368B2 (ja) * 1980-10-30 1983-09-27 日東電工株式会社 消炎鎮痛貼付剤
JPS57142258A (en) * 1981-02-27 1982-09-02 Nitto Electric Ind Co Drug containing tape preparation
JPS57179271A (en) * 1981-04-28 1982-11-04 Sekisui Chem Co Ltd Remedial adhesive tape or sheet
JPS6066759A (ja) * 1983-09-21 1985-04-16 日東電工株式会社 医薬製剤
JPS60123417A (ja) * 1983-12-07 1985-07-02 Nitto Electric Ind Co Ltd 薬物投与部材
GB2156215B (en) * 1984-03-05 1988-03-02 Nitto Electric Ind Co Percutaneous absorption type adhesive pharmaceutical preparation
US4655768A (en) * 1984-07-06 1987-04-07 Avery International Corporation Bandage for sustained delivery of drugs
ATE59302T1 (de) * 1984-07-24 1991-01-15 Key Pharma Klebende schicht zur transdermalen freigabe.
AU563054B2 (en) * 1984-10-24 1987-06-25 Sekisui Kagaku Kogyo Kabushiki Kaisha Percutaneous tape of isdn
JPS61280426A (ja) * 1985-06-04 1986-12-11 Ikeda Mohandou:Kk 消炎鎮痛用貼付剤
DE3682165D1 (de) * 1985-11-08 1991-11-28 Nitto Denko Corp Verwendung von heftpflastern fuer die haut und perkutanen praeparaten.
US4759816A (en) * 1986-07-07 1988-07-26 Schoeller Technical Papers, Inc. Strippable film for adhesive coating and laminating
US4906475A (en) * 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
DE68917292T2 (de) * 1988-02-26 1995-02-02 Riker Laboratories Inc Transdermales estradiol als therapeutisches sytem.

Also Published As

Publication number Publication date
DE69023992D1 (de) 1996-01-18
CA2065311A1 (en) 1991-03-09
JPH05500510A (ja) 1993-02-04
JP2718433B2 (ja) 1998-02-25
EP0416842B1 (de) 1995-12-06
AU644815B2 (en) 1993-12-23
WO1991003219A1 (en) 1991-03-21
JP2974969B2 (ja) 1999-11-10
FI920960A0 (fi) 1992-03-04
PT95245B (pt) 2001-05-31
IE71048B1 (en) 1997-01-15
JP2000026284A (ja) 2000-01-25
EP0416842A1 (de) 1991-03-13
IE903259A1 (en) 1991-03-13
DK0416842T3 (da) 1996-01-02
GR3019124T3 (en) 1996-05-31
NO920832D0 (no) 1992-03-03
NO920832L (no) 1992-03-03
CA2065311C (en) 2000-01-11
JPH09100227A (ja) 1997-04-15
NO303262B1 (no) 1998-06-22
NZ235068A (en) 1993-05-26
AU6441590A (en) 1991-04-08
FI107708B (fi) 2001-09-28
PT95245A (pt) 1991-08-14
DE69023992T2 (de) 1996-04-25
ES2081352T3 (es) 1996-03-01

Similar Documents

Publication Publication Date Title
ATE131074T1 (de) Festes matrixsystem zur transdermalen arzneimittelfreisetzung.
ES2071683T3 (es) Sistema de suministro de un farmaco transdermico a base de multipolimero acrilico.
ATE235898T1 (de) Als löslichkeit-steigernde gebrauchte polyvinylpyrrolidon enthaltende transdermale vorrichtung
AU578299B2 (en) Drug delivery device with constant release rate of its active principle
NZ235581A (en) Controlled release plaster comprising a pressure-sensitive acrylic/methacrylic acid polymer adhesive with active substances dissolved therein
FI960556A0 (fi) Transdermaalinen aktiivisten lääkeaineiden hitaan virtauksen antojärjestelmä
EP0279977A3 (de) Transdermale Verabreichung von Progesteron, Östradiolestern und deren Mischungen
AU7465087A (en) Controlled release bioerodible drug delivery system
KR910700044A (ko) 에스트로겐/프로게스틴 경피용량 단위, 시스템 및 방법
CA2193129A1 (en) Transdermal drug delivery system
DE69133623D1 (de) Haltende neue pharmazeutische formulierungen sowie verfahren zu deren herstellung
UA29400C2 (uk) Пластир для трансдермального введення нітрогліцерину та спосіб його виготовлення
GR3018303T3 (en) Transdermal estradiol delivery system.
DE3789288D1 (de) Basische, wirkstoffdurchlässige haftklebende Polymermasse, Verfahren zu ihrer Herstellung und ihre Verwendung.
ATE69724T1 (de) Selbstklebende vorrichtung zur transdermalen verabreichung eines wirkstoffs.
DK0474647T3 (da) Fremgangsmåde og indretning til frigivelse af lægemidler til huden
DE3367324D1 (en) Pharmaceutical products in sustained-release form, and their preparation process
PL319259A1 (en) Scopolamine containing plaster
ATE295157T1 (de) Mittel zur transdermalen verabreichung von arzneistoffen
ATE78707T1 (de) Transdermale arzneimitteleinzeldosis gegen angina und verfahren zu ihrer verabreichung.
TW273516B (en) Adhesive matrix-type transdermal therapeutic set for motion sickness

Legal Events

Date Code Title Description
RZN Patent revoked